It mediates the recruitment of myeloid-derived suppressor cells (MDSCs) and inactivates cytotoxic CD8<sup>+</sup> T cells and natural killer (NK) cells, thereby fostering an immunosuppressive tumor microenvironment and resistance to checkpoint inhibitors. This evidence concerns the gene CD8A and neoplasm.